Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Background and Objectives The onset of action for high-efficacy immunotherapies in multiple sclerosis (MS) is an important parameter. This study (MAGNIFY-MS) evaluates the onset...

Multiple sclerosis (MS) has historically been underdiagnosed and undertreated among African Americans. Recent evidence suggests that African Americans with MS have a different clinical...

By complementing spatial transcriptomics with high-resolution proteomics, Kaufmann et al. tracked a gradient of disease severity across the brains of patients with progressive multiple...

Background and Objectives The relationship between smoking, long-term brain atrophy, and clinical disability in patients with multiple sclerosis (MS) is unclear. Here, we assessed...

Mashup Score:1

lww.com

Wolters Kluwer Health - 1 week

Mashup Score:1

JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers:...

Background and Objectives The COVID-19 pandemic has dramatically increased telehealth use. We assessed access to and use of telehealth care, including videoconferencing and usability...

As previously reported, ponesimod (Ponvory; Janssen Pharmaceuticals, Titusville, NJ) significantly reduced the annualized rate of relapse (ARR) in...

As published in Annals of Clinical and Translational Neurology, vidofludimus calcium (VFC) (IMU-838; Immunic Therapeutics, New York, NY)...

The RELEASE MSS1 trial included adults with a confirmed diagnosis of any disease subtype of multiple...